Aviva (OTCMKTS:AVVIY) Stock Rating Upgraded by Wall Street Zen

Key Points

• Aviva's stock has been upgraded from a "hold" to a "buy" rating by Wall Street Zen, indicating positive sentiment among analysts.
• Despite the upgrade, Barclays recently downgraded Aviva from a "strong-buy" to a "hold," contributing to a mixed outlook with a consensus rating of "Moderate Buy".
• As of the latest trading session, Aviva's stock price reached $18.07, with a 52-week range between $11.49 and $19.00.

Aviva (OTCMKTS:AVVIY - Get Free Report) was upgraded by Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued to investors on Saturday.

AVVIY has been the topic of a number of other reports. Barclays cut Aviva from a "strong-buy" rating to a "hold" rating in a research note on Monday, June 16th. Citigroup raised Aviva to a "hold" rating in a report on Tuesday, July 15th. Two analysts have rated the stock with a Strong Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy".

Aviva Price Performance

OTCMKTS AVVIY traded up $0.43 during mid-day trading on Friday, hitting $18.07. The company's stock had a trading volume of 24,079 shares, compared to its average volume of 82,364. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.86 and a current ratio of 1.86. The company's 50 day simple moving average is $17.68 and its 200 day simple moving average is $15.99. Aviva has a twelve month low of $11.49 and a twelve month high of $19.00.

About Aviva

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.